Found 141 clinical trials
BEACON: HDR Brachytherapy, EBRT and STAD for the Treatment of Local and Pelvic Recurrence of Prostate Cancer After Radiation Therapy (BEACON)
The purpose of this study is to evaluate the safety and effectiveness of combining high-dose-rate (HDR) brachytherapy with external beam radiotherapy (EBRT) to the pelvis and 6 months of
- 9 views
- 04 Mar, 2022
- 1 location
Radioligand fOr locAl raDiorecurrent proStaTe cancER (ROADSTER)
Approximately 50-60% of men undergoing salvage brachytherapy post cancer recurrence to the prostate have the disease controlled at 5 years. This study aims to integrate a local treatment to the
- 0 views
- 02 Jun, 2022
- 1 location
Twice High Dose External Beam Radiotherapy by Image-guided Tomotherapy for Organ-confined Prostate Cancer Treatment Emulating High Dose Radiation (HDR) Brachytherapy
Feasibility trial of twice high dose radiotherapy using Tomotherapy in patients with organ confined Prostate Cancer histologically proven. The study involves 2 steps: Assessment of safety as proportion of patients with acute G3 Genito-urinary (GU) and Gastro-intestinal (GI) side effects on the first 16 enrolled patients; B) evaluation of primary …
- 0 views
- 24 Jan, 2021
- 1 location
IMMULAB - Immunotherapy With Pembrolizumab in Combination With Local Ablation in Hepatocellular Carcinoma (HCC)
patients who are candidates for local ablation via either radiofrequency ablation (RFA) or microwave ablation (MWA) or brachytherapy or combination of TACE with RFA, MWA or brachytherapy.
- 1 views
- 09 Feb, 2022
- 1 location
HDR Focal: Feasibility Study
Brachytherapy as a monotherapy treatment is highly effective for localized prostate cancer, traditionally being delivered to the whole prostate gland. Lately, low dose rate (LDR) brachytherapy
- 120 views
- 24 Feb, 2022
- 1 location
Radiosensitizing Effect of Nelfinavir in Locally Advanced Carcinoma of Cervix (NELCER)
Radiotherapy). There will be two study groups. One group will receive standard treatment (concurrent chemoradiation and brachytherapy) & other group will receive nelfinavir 5-7 days prior to
- 1 views
- 12 Mar, 2022
- 1 location
SBRT vs. Conventional Fractionation With HDR Boost for Prostate Cancer (SHARP)
Random assignment between SBRT and conventionally fractionated boost following HDR brachytherapy for prostate cancer.
- 0 views
- 10 May, 2022
- 1 location
Salvage HDR for Locally Recurrent Prostate Cancer
The study offers focal salvage brachytherapy for prostate cancer patients with a local recurrence after primary defintive radiotherapy
- 0 views
- 02 Aug, 2021
- 1 location
Trial of Quercetin, Bromelain, Rye Flower Pollen & Papain on Reducing Severity of Radiation-Induced Prostatitis (Q-Urol)
This study will assess the difference in prostatitis symptoms in men with localized prostate cancer following brachytherapy taking Q-Urol relative to placebo.
- 0 views
- 28 Jun, 2022
- 2 locations
Feasibility of ReSpace™ Hydrogel to Establish a Stable Cervical-rectal Space
In this study, 5 subjects will be enrolled and the cumulative D2cc dose for rectum during brachytherapy will be recorded as the primary outcome measures.
- 0 views
- 25 May, 2022
- 1 location